Alex Reid Hastie - 03 Aug 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Reporting relationship: Chief Scientific Officer
Issuer ticker: BNGO
Reported as of: 03 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2026, 17:26:42 UTC
Prior SEC filing: 30 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan V. Dixon, Attorney-in-Fact

Key filing fact

Alex Reid Hastie filed Form 4 for Bionano Genomics, Inc. (BNGO) on 05 Aug 2026.

Key facts

This page summarizes Alex Reid Hastie's Form 4 filing for Bionano Genomics, Inc. (BNGO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2026, 17:26.

Change

Previous filing in this sequence was filed on 30 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147380 Primary reporting owner

Hastie Alex Reid

Relationship: Chief Scientific Officer
Address: C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Signature date: 05 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BNGO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +54,000
Change %
Price: $0.000000^*
Shares after: 54,000
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 54,000
Exercise price: $1.12
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

25% of the shares subject to the option shall vest and become exercisable on August 2, 2027, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from August 2, 2027, subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each such applicable vesting date.

Footnote F2

The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed.